SIRT5 and Myocardial fibrosis: Results revealed that, compared to WT controls, liver-specific SIRT5-overexpressing mice exhibited markedly reduced MI area and degree of myocardial fibrosis, accompanied by significantly elevated levels of secreted fibroblast growth factor 21 (FGF21) in the circulation.